Status:
COMPLETED
HPV Vaccination Health-promotion Programme on Vaccine Acceptance and Uptake Among Female Adolescents
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
HPV Infection
Health Behavior
Eligibility:
FEMALE
14-17 years
Phase:
NA
Brief Summary
The MDL-SHPVP will be developed and a clustered randomised controlled trial will be conducted to evaluate the effects of the MDL-SHPVP and to examine whether the effect of the MDL-SHPVP on the rate of...
Detailed Description
2520 adolescents and their parents or guardians from 18 local secondary day schools will be recruited. Multicomponent interventions will be offered to the intervention schools. To build and strengthen...
Eligibility Criteria
Inclusion
- Female;
- Age 14-17 years;
Exclusion
- Have received the HPV vaccination before
Key Trial Info
Start Date :
December 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 28 2024
Estimated Enrollment :
1340 Patients enrolled
Trial Details
Trial ID
NCT04438291
Start Date
December 1 2020
End Date
May 28 2024
Last Update
September 4 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Chinese University of Hong Kong
Shatin, Hong Kong